References
- Wu X, Shi Q, Shen S, Huang C, Wu H. Clinical and bacterial characteristics of Klebsiella pneumoniae affecting 30-day mortality in patients with bloodstream infection. Front Cell Infect Microbiol. 2021;11:688989. doi:10.3389/fcimb.2021.688989
- Karampatakis T, Antachopoulos C, Iosifidis E, et al. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece. Future Microbiol. 2016;11:809–823. doi:10.2217/fmb-2016-0042
- Ventola CL. The antimicrobials resistance crisis: part 1: causes and threats. Pharm Ther. 2015;40:277–283.
- Haigh JD, Green IM, Ball D, et al. Rapid identification of bacteria from bioMérieux BacT/ALERT blood culture bottles by MALDI-TOF MS. Br J Biomed Sci. 2013;70:149–155. doi:10.1080/09674845.2013.11669949
- Sakarikou C, Ciotti M, Dolfa C, et al. Rapid detection of carbapenemase-producing Klebsiella pneumoniae strains derived from blood cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). BMC Microbiol. 2017;17(1):54. doi:10.1186/s12866-017-0952-3
- Fangous M-S, Mougari F, Gouriou S, et al. Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2014;52:3362–3369. doi:10.1128/JCM.00788-14
- Mather CA, Werth BJ, Sivagnanam S, et al. Rapid detection of vancomycin-intermediate Staphylococcus aureus by Matrix-assisted laser desorption ionization-time of flight massspectrometry. J Clin Microbiol. 2016;54(4):883–890. doi:10.1128/JCM.02428-15
- CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI document M100-S27. Wayne, PA: CLSI; 2018.
- Pena I, Pena-Vina E, Rodriguez-Avial I, et al. Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates [published online ahead of print, 2020 Dec 15]. Enferm Infecc Microbiol Clin. 2020;40(4):172–178.
- Hussein K, Raz-Pasteur A, Finkelstein R. Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiellapneumoniae. J Hosp Infect. 2013;83(83):307–313. doi:10.1016/j.jhin.2012.10.012
- Li C, Wen X, Ren N, et al. Point-prevalence of healthcare-associated infection in China in 2010: a large multicenter epidemiological survey. Infect Control Hosp Epidemiol. 2014;35(11):1436–1437. doi:10.1086/678433
- Meng X, Liu S, Duan J, et al. Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital. BMC Infect Dis. 2017;17(1):82. doi:10.1186/s12879-016-2176-9
- Arato V, Raso MM, Gasperini G, et al. Prophylaxis and treatment against Klebsiella pneumoniae: current insights on this emerging anti-microbial resistant global threat. Int J Mol Sci. 2021;22(8):4042. doi:10.3390/ijms22084042
- Wang G, Song G, Xu Y. A rapid antimicrobial susceptibility test for Klebsiella pneumoniae using a broth micro-dilution combined with MALDI TOF MS. Infect Drug Resist. 2021;14:1823–1831. doi:10.2147/IDR.S305280
- Liu X, Su T, Hsu YS, et al. Rapid identification and discrimination of methicillin-resistant Staphylococcus aureus strains via matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2021;35(2):e8972. doi:10.1002/rcm.8972
- Huang TS, Lee SS, Lee CC, et al. Detection of carbapenem-resistant Klebsiella pneumoniae on the basis of matrix-assisted laser desorption ionization time-of-flight mass spectrometry by using supervised machine learning approach. PLoS One. 2020;15(2):e0228459. doi:10.1371/journal.pone.0228459
- Esener N, Green MJ, Emes RD, et al. Discrimination of contagious and environmental strains of Streptococcus uberis in dairy herds by means ofmass spectrometry and machine-learning. Sci Rep. 2018;8:17517. doi:10.1038/s41598-018-35867-6
- Pérez-Sancho M, Vela AI, Horcajo P, et al. Rapid differentiation of Staphylococcus aureus subspecies based on MALDI-TOF MS profiles. J Vet Diagn Invest. 2018;30:813–820. doi:10.1177/1040638718805537